|
|
||||||||
University of Michigan, Ann Arbor, Michigan
Correspondence: For reprints contact: Dr. B. Shapiro, Div. of Nucl. Med., University of Michigan Hospitals, Ann Arbor, MI 48109.
ABSTRACT
Heart intensity (HI) in the 24- and 48-hr images of meta-[131I]iodobenzylguanidine (I-131 MIBG), a pheochromocytoma-seeking guanethidine analog, were compared with concentrations of plasma and urinary catecholamines and their metabolites in nonpheochromocytoma and pheochromocytoma patients. HI was inversely related to plasma concentrations and urinary excertion rates of the hormones. Plasma norespinephrine had the highest inverse correlation with HI (r = 0.73 at 24 hr, 0.63 at 48 hr), and urinary metanephrine the lowest (r = 0.23 at 24 hr, 0.28 at 48 hr). A similar relationship was observed in the intensity of salivary-gland visualization, but with less marked variations. HI was much higher in nonpheochromocytoma patients than in pheochromocytoma patients. HI in an I-131 MIBG image provides useful information in the diagnosis of pheochromocytoma, and may provide a tool for the study of the influence of catecholamines on the heart.
This article has been cited by other articles:
![]() |
R. Pop-Busui, I. Kirkwood, H. Schmid, V. Marinescu, J. Schroeder, D. Larkin, E. Yamada, D. M. Raffel, and M. J. Stevens Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2368 - 2374. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Konno, T. Araki, R. Soma, H. Takimoto, Y. Tofuku, and M. Shimizu Remarkable Improvement of Myocardial Metaiodobenzylguanidine Uptake After Surgery in a Patient with Pheochromocytoma: A Case Report Angiology, September 1, 2004; 55(5): 565 - 567. [Abstract] [PDF] |
||||
![]() |
B. A. Eldadah, K. Pacak, G. Eisenhofer, C. Holmes, I. J. Kopin, and D. S. Goldstein Cardiac Uptake-1 Inhibition by High Circulating Norepinephrine Levels in Patients with Pheochromocytoma Hypertension, June 1, 2004; 43(6): 1227 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Druschky, M. J. Hilz, P. Hopp, G. Platsch, M. Radespiel-Troger, K. Druschky, T. Kuwert, H. Stefan, and B. Neundorfer Interictal cardiac autonomic dysfunction in temporal lobe epilepsy demonstrated by [123I]metaiodobenzylguanidine-SPECT Brain, December 1, 2001; 124(12): 2372 - 2382. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Momose, H. Kobayashi, H. Ikegami, H. Nagamatsu, Y. Sakomura, S. Aomi, H. Kasanuki, and K. Kusakabe Total and Partial Cardiac Sympathetic Denervation After Surgical Repair of Ascending Aortic Aneurysm J. Nucl. Med., September 1, 2001; 42(9): 1346 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.N Simantirakis, V.K Prassopoulos, S.I Chrysostomakis, G.E Kochiadakis, S.I Koukouraki, J.P Lekakis, N.S Karkavitsas, and P.E Vardas Effects of asynchronous ventricular activation on myocardial adrenergic innervation in patients with permanent dual-chamber pacemakers. An I123-metaiodobenzylguanidine cardiac scintigraphic study Eur. Heart J., February 2, 2001; 22(4): 323 - 332. [Abstract] [PDF] |
||||
![]() |
S. Braune, M. Reinhardt, R. Schnitzer, A. Riedel, and C. H. Lucking Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy Neurology, September 1, 1999; 53(5): 1020 - 1020. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |